Longitudinal study of effects of patient characteristics on direct costs in Alzheimer disease
Authors:
- C. W. ZhuCZC. W. Zhu
- N. ScarmeasNSN. Scarmeas
- R. TorganRTR. Torgan
- M. AlbertMAM. Albert
- J. BrandtJ. Brandt
- D. BlackerDBD. Blacker
- M. SanoMSM. Sano
- Y. SternYSY. Stern
- 26 September 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 67 (6) , 998-1005
Abstract
Objectives: To estimate long-term trajectories of direct cost of caring for patients with Alzheimer disease (AD) and examine the effects of patients’ characteristics on cost longitudinally. Methods: The sample is drawn from the Predictors Study, a large, multicenter cohort of patients with probable AD, prospectively followed up annually for up to 7 years in three university-based AD centers in the United States. Random effects models estimated the effects of patients’ clinical and sociodemographic characteristics on direct cost of care. Direct cost included cost associated with medical and nonmedical care. Clinical characteristics included cognitive status (measured by Mini-Mental State Examination), functional capacity (measured by Blessed Dementia Rating Scale [BDRS]), psychotic symptoms, behavioral problems, depressive symptoms, extrapyramidal signs, and comorbidities. The model also controlled for patients’ sex, age, and living arrangements. Results: Total direct cost increased from approximately $9,239 per patient per year at baseline, when all patients were at the early stages of the disease, to $19,925 by year 4. After controlling for other variables, a one-point increase in the BDRS score increased total direct cost by 7.7%. One more comorbid condition increased total direct cost by 14.3%. Total direct cost was 20.8% lower for patients living at home compared with those living in an institutional setting. Conclusions: Total direct cost of caring for patients with Alzheimer disease increased substantially over time. Much of the cost increases were explained by patients’ clinical and demographic variables. Comorbidities and functional capacity were associated with higher direct cost over time.Keywords
This publication has 41 references indexed in Scilit:
- The Economic Impact of Neuropsychiatric Symptoms in Alzheimer???s DiseasePharmacoEconomics, 2005
- Cost of Illness of Alzheimer's Disease: How Useful Are Current Estimates?The Gerontologist, 2003
- Cost of dementia: impact of disease progression estimated in longitudinal dataScandinavian Journal of Public Health, 2003
- Medical Expenditures during the Last Year of Life: Findings from the 1992–1996 Medicare Current Beneficiary SurveyHealth Services Research, 2002
- Economic impact of Alzheimer's disease in the United KingdomThe British Journal of Psychiatry, 1999
- Clinical Predictors of the Indirect Costs of Alzheimer DiseaseArchives of Neurology, 1998
- Multicenter Study of Predictors of Disease Course in Alzheimer Disease (the “Predictors Study”). II. Neurological, Psychiatric, and Demographic Influences on Baseline Measures of Disease SeverityAlzheimer Disease & Associated Disorders, 1993
- Multicenter Study of Predictors of Disease Course in Alzheimer Disease (the “Predictors Study”). I. Study Design, Cohort Description, and Intersite ComparisonsAlzheimer Disease & Associated Disorders, 1993
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987
- A New Clinical Scale for the Staging of DementiaThe British Journal of Psychiatry, 1982